Goldman Sachs Group Inc Mereo Biopharma Group PLC Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,008,381 shares of MREO stock, worth $7.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,008,381
Previous 2,507,513 19.91%
Holding current value
$7.09 Million
Previous $9.03 Million 8.56%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.45 - $4.87 $1.72 Million - $2.43 Million
-499,132 Reduced 19.91%
2,008,381 $8.25 Million
Q2 2024

Aug 13, 2024
BUY
$2.58 - $4.25 $680,343 - $1.12 Million
263,699 Added 11.75%
2,507,513 $9.03 Million
Q1 2024

May 15, 2024
BUY
$2.3 - $4.05 $506,326 - $891,575
220,142 Added 10.88%
2,243,814 $7.4 Million
Q3 2023

Nov 14, 2023
BUY
$1.15 - $1.67 $47,455 - $68,914
41,266 Added 2.08%
2,023,672 $2.61 Million
Q2 2023

May 14, 2024
SELL
$0.79 - $1.43 $221,499 - $400,941
-280,379 Reduced 12.39%
1,982,406 $2.62 Million
Q2 2023

Aug 14, 2023
SELL
$0.79 - $1.43 $221,499 - $400,941
-280,379 Reduced 12.39%
1,982,406 $2.62 Million
Q1 2023

May 14, 2024
SELL
$0.71 - $1.22 $22,706 - $39,016
-31,981 Reduced 1.39%
2,262,785 $1.61 Million
Q1 2023

May 11, 2023
SELL
$0.71 - $1.22 $22,706 - $39,016
-31,981 Reduced 1.39%
2,262,785 $1.61 Million
Q4 2022

May 14, 2024
BUY
$0.5 - $1.01 $792,820 - $1.6 Million
1,585,640 Added 223.6%
2,294,766 $1.72 Million
Q4 2022

Feb 13, 2023
BUY
$0.5 - $1.01 $792,820 - $1.6 Million
1,585,640 Added 223.6%
2,294,766 $1.72 Million
Q3 2022

May 14, 2024
SELL
$0.82 - $1.73 $6,829 - $14,409
-8,329 Reduced 1.16%
709,126 $611,000
Q3 2022

Nov 10, 2022
SELL
$0.82 - $1.73 $6,829 - $14,409
-8,329 Reduced 1.16%
709,126 $0
Q2 2022

May 14, 2024
SELL
$0.33 - $1.69 $431,051 - $2.21 Million
-1,306,217 Reduced 64.55%
717,455 $804,000
Q2 2022

Aug 15, 2022
BUY
$0.33 - $1.69 $749 - $3,836
2,270 Added 0.32%
717,455 $804,000
Q1 2022

May 16, 2022
BUY
$1.04 - $1.7 $2,934 - $4,797
2,822 Added 0.4%
715,185 $801,000
Q4 2021

Feb 14, 2022
BUY
$1.51 - $2.59 $1.08 Million - $1.85 Million
712,363 New
712,363 $1.14 Million

Others Institutions Holding MREO

# of Institutions
85
Shares Held
107M
Call Options Held
209K
Put Options Held
479K
View Full List

About Mereo Biopharma Group plc

MREO Quotes by TradingView
  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $441M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email